1. Home
  2. GNFT vs BW Comparison

GNFT vs BW Comparison

Compare GNFT & BW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNFT
  • BW
  • Stock Information
  • Founded
  • GNFT 1999
  • BW 1867
  • Country
  • GNFT France
  • BW United States
  • Employees
  • GNFT N/A
  • BW N/A
  • Industry
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • BW Building Products
  • Sector
  • GNFT Health Care
  • BW Industrials
  • Exchange
  • GNFT Nasdaq
  • BW Nasdaq
  • Market Cap
  • GNFT 179.7M
  • BW 182.0M
  • IPO Year
  • GNFT 2019
  • BW N/A
  • Fundamental
  • Price
  • GNFT $3.91
  • BW $1.43
  • Analyst Decision
  • GNFT Strong Buy
  • BW Strong Buy
  • Analyst Count
  • GNFT 1
  • BW 3
  • Target Price
  • GNFT $13.00
  • BW $4.50
  • AVG Volume (30 Days)
  • GNFT 9.9K
  • BW 1.1M
  • Earning Date
  • GNFT 09-19-2024
  • BW 03-13-2025
  • Dividend Yield
  • GNFT N/A
  • BW N/A
  • EPS Growth
  • GNFT N/A
  • BW N/A
  • EPS
  • GNFT 0.47
  • BW N/A
  • Revenue
  • GNFT $86,225,222.00
  • BW $878,224,000.00
  • Revenue This Year
  • GNFT $145.20
  • BW N/A
  • Revenue Next Year
  • GNFT N/A
  • BW N/A
  • P/E Ratio
  • GNFT $7.89
  • BW N/A
  • Revenue Growth
  • GNFT 175.45
  • BW N/A
  • 52 Week Low
  • GNFT $3.35
  • BW $0.75
  • 52 Week High
  • GNFT $6.42
  • BW $2.99
  • Technical
  • Relative Strength Index (RSI)
  • GNFT 54.95
  • BW 40.19
  • Support Level
  • GNFT $3.68
  • BW $1.27
  • Resistance Level
  • GNFT $3.96
  • BW $1.43
  • Average True Range (ATR)
  • GNFT 0.13
  • BW 0.09
  • MACD
  • GNFT 0.05
  • BW 0.00
  • Stochastic Oscillator
  • GNFT 79.49
  • BW 30.23

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

About BW Babcock & Wilcox Enterprises Inc.

Babcock & Wilcox Enterprises Inc is a power generation equipment supplier and servicing company that operates in three segments: B&W Renewable, B&W Environmental, and B&W Thermal. B&W Thermal, focuses on steam generation products and solutions for plants in the power generation, oil, and gas, and industrial sectors, generates the majority of the company's revenue. B&W Renewable focuses on sustainable power and heat generation while B&W Environmental focuses on emissions control. The company's customer base spans the industrial, electrical utility, and municipal industries located predominantly in the United States, Canada, Denmark, the United Kingdom, and other regions. Business in the U.S. contributes the vast majority of its revenue.

Share on Social Networks: